Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Baldwin, David S.
and
Birtwistle, Jon
2000.
Anxiolytics.
p.
55.
Kasper, Siegfried
and
Resinger, Eva
2001.
Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors.
European Neuropsychopharmacology,
Vol. 11,
Issue. 4,
p.
307.
Scott, Allan
Davidson, Alan
and
Palmer, Karen
2001.
Antidepressant drugs in the treatment of anxiety disorders.
Advances in Psychiatric Treatment,
Vol. 7,
Issue. 4,
p.
275.
Rapaport, Mark Hyman
Wolkow, Robert
Rubin, Arkady
Hackett, Elizabeth
Pollack, Mark
and
Ota, Kay Y.
2001.
Sertraline treatment of panic disorder: results of a long‐term study.
Acta Psychiatrica Scandinavica,
Vol. 104,
Issue. 4,
p.
289.
Dunner, David L.
2001.
Management of anxiety disorders: The added challenge of comorbidity.
Depression and Anxiety,
Vol. 13,
Issue. 2,
p.
57.
Rapaport, Mark Hyman
Wolkow, Robert
Rubin, Arkady
Hackett, Elizabeth
Pollack, Mark
and
Ota, Kay Y.
2001.
Sertraline treatment of panic disorder: results of a long‐term study.
Acta Psychiatrica Scandinavica,
Vol. 104,
Issue. 4,
p.
289.
Simon, Naomi M
Safren, Steven A
Otto, Michael W
Sharma, Saumya G
Lanka, Gretchen D
and
Pollack, Mark H
2002.
Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder.
Journal of Affective Disorders,
Vol. 69,
Issue. 1-3,
p.
201.
Martenyi, Ferenc
Brown, Eileen B.
Zhang, Harry
Koke, Stephanie C.
and
Prakash, Apurva
2002.
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder.
British Journal of Psychiatry,
Vol. 181,
Issue. 4,
p.
315.
Emilien, Gérard
Dinan, Timothy
Lepola, Ulla Marjatta
and
Durlach, Cécile
2002.
Anxiety Disorders.
p.
133.
Díez-Quevedo, Crisanto
Rangil, Teresa
and
Sánchez Planell, Luis
2002.
Agorafobia.
Medicina Clínica,
Vol. 119,
Issue. 2,
p.
60.
Ballenger, J.C.
2002.
Anxiety Disorders.
p.
339.
Möller, H. J.
Grunze, H.
Hegerl, U.
Henkel, V.
Bauer, M.
Laux, G.
Boerner, R. J.
Broocks, A.
Kordon, A.
Hohagen, F.
Fichter, M. M.
and
Würz, R.
2002.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
651.
Pollack, Mark H.
Allgulander, Christer
Bandelow, Borwin
Cassano, Giovanni B.
Greist, John H.
Hollander, Eric
Nutt, David J.
Okasha, Ahmed
and
Swinson, Richard P.
2003.
WCA Recommendations for the Long-Term Treatment of Panic Disorder.
CNS Spectrums,
Vol. 8,
Issue. S1,
p.
17.
Zohar, Joseph
2003.
WCA Recommendations for the Long-Term Treatment of Anxiety Disorders.
CNS Spectrums,
Vol. 8,
Issue. S1,
p.
5.
Heuzenroeder, Louise
Donnelly, Marie
Haby, Michelle M.
Mihalopoulos, Cathrine
Rossell, Ruth
Carter, Rob
Andrews, Gavin
and
Vos, Theo
2004.
Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder.
Australian & New Zealand Journal of Psychiatry,
Vol. 38,
Issue. 8,
p.
602.
Heuzenroeder, Louise
Donnelly, Marie
Haby, Michelle M.
Mihalopoulos, Cathrine
Rossell, Ruth
Carter, Rob
Andrews, Gavin
and
Vos, Theo
2004.
Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder.
Australian & New Zealand Journal of Psychiatry,
Vol. 38,
Issue. 8,
p.
602.
Bandelow, Borwin
and
Rüther, Eckart
2004.
Treatment-Resistant Panic Disorder.
CNS Spectrums,
Vol. 9,
Issue. 10,
p.
725.
Nash, J.R.
and
Nutt, D.J.
2005.
Anxiety and Anxiolytic Drugs.
Vol. 169,
Issue. ,
p.
469.
Stevens, Julie C.
and
Pollack, Mark H.
2005.
Pharmacologic Treatment of Panic Disorder.
CNS Spectrums,
Vol. 10,
Issue. S12,
p.
25.
Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Bandelow, Borwin
Bond, A.
Davidson, Jonathan R. T.
den Boer, J. A.
Fineberg, Naomi A.
Knapp, Martin
Scott, J.
and
Wittchen, H. -U.
2005.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology,
Vol. 19,
Issue. 6,
p.
567.
eLetters
No eLetters have been published for this article.